Streetbeat News

Stock Prices

SG

Sweetgreen shares rose after TD Cowen upgraded the stock from Hold to Buy and increased its price target from $31 to $43.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:23 pm

HQY

HealthEquity shares rose following the release of their Q2 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:21 pm

ATHM

Autohome's shares are rising following the announcement of a new share repurchase program worth up to $200 million.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:18 pm

AAOI

Applied Optoelectronics (NASDAQ:AAOI) has seen a surge in options activity, with a significant amount of bullish sentiment from big-money traders. The stock is currently trading at $13.45, up 9.71%, and analysts have mixed ratings with price targets ranging from $9 to $17. The options activity suggests a focus on a price range between $10 and $17.5.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 3:15 pm

MRNA

Recent options trading activity for Moderna (NASDAQ:MRNA) shows a bearish sentiment among large investors, with 63% of trades being bearish. The price target for MRNA is between $69.0 and $160.0. Analysts have mixed ratings, with an average target price of $83.33.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 3:15 pm

LRCX

Recent options trading trends for Lam Research (NASDAQ:LRCX) show a significant increase in activity, with a mix of bullish and bearish sentiments. Wealthy investors or institutions are speculated to be behind these trades, indicating potential upcoming developments for the company. The options trades suggest a targeted price range of $600 to $1040 for LRCX.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 3:15 pm

ERJ

Embraer shares rise as TD Cown upgrades the stock from Hold to Buy, increasing the price target from $26 to $41.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:14 pm

BIOA

LLY

NVO

BioAge Labs Inc, a biotech company, has filed for a $100 million IPO to be listed on Nasdaq under the symbol BIOA. The company is developing obesity drugs, with its lead drug Azelaprag showing promising results in preclinical trials. BioAge plans to conduct Phase 2 trials in combination with drugs from Eli Lilly and Novo Nordisk.

Portfolio Pulse from Vandana Singh

September 04, 2024 | 3:13 pm

PACS

PACS Group's stock is trading lower following the announcement of a public offering of 13.88 million shares of its common stock.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:11 pm

HLX

PXJ

SHEL

SLB

Helix Energy Solutions Group, Inc. (NYSE:HLX) has secured a multi-year agreement with Shell Offshore Inc, a unit of Shell PLC (NYSE:SHEL), to provide well intervention services in the U.S. Gulf of Mexico starting in 2025. The contract reflects improving market conditions and increased demand for Helix's services. Helix will use its Q5000 vessel and other equipment, in collaboration with Schlumberger (NYSE:SLB), to deliver integrated operations. HLX shares have gained over 4.9% in the past month.

Portfolio Pulse from Nabaparna Bhattacharya

September 04, 2024 | 3:08 pm